Dallas, TXNCT07622927Now EnrollingIRB Ready

Bipolar Disorder (BD) Clinical Trial in Dallas, TX

Access cutting-edge bipolar disorder (bd) treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by University of Texas Southwestern Medical Center

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access bipolar disorder (bd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bipolar disorder (bd) treatment provided free

Apply for This Dallas Location

Check if you qualify for this bipolar disorder (bd) clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Bipolar Disorder (BD) Study in Dallas

Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder. The main questions addressed by this project are: Whether a co-designed video decision aid improves caregiver understanding of bipolar disorder genetic risk and supports informed decisions about youth screening. Whether remote mental health screening tools are feasible and acceptable for youth with familial risk for bipolar disorder. Whether screening results can be used to identify early risk patterns and inform tailored follow-up recommendations. Participants may be involved in one or more study activities, including co-design of educational decision-aid content, feedback on decision-aid prototypes, beta testing of the decision aid, and remote youth mental health screening. The study does not assign treatment and does not change existing clinical care or clinic routines.

Sponsor: University of Texas Southwestern Medical Center

Who Can Participate

Inclusion Criteria

for Group A - Parent with Bipolar Disorder:
Age: 18 years or older.
Confirmation of a lifetime Bipolar I or II diagnosis
Parent status: Has at least one biological child aged 7-21 years.
Capacity and willingness to consent: Able and willing to provide informed consent.
Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments).
Language: Able to read, speak, and understand English. Inclusion Criteria for Group B - Adult Caregiver:
Age: 18 years or older.
Caregiver status: The adult primarily responsible for the daily care and/or medical decisions for ≥ 6 months for a child aged 7-21 years whose biological parent has a lifetime, clinician-confirmed diagnosis of Bipolar I or II disorder.
Capacity and willingness to consent: Able and willing to provide informed consent.
Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments).
Language: Able to read, speak, and understand English. Inclusion Criteria for Group C - At-Risk Youth:
Phase 1 (co-design) and Phase 2A (alpha testing): 13-18 years
Phase 2B (beta testing): 13-18 years
Phase 3 (screening): 7-21 years
Diagnosis status: Must not have a current diagnosis of Bipolar I or II disorder.
Parental diagnosis: Has at least 1 biological parent with a lifetime, clinician-confirmed Bipolar I or II diagnosis (as defined in Groups A and B).
Consent/Assent:
For youth aged 18-21: Able and willing to provide informed consent (verbal)
For youth aged 7-21: Parent/guardian/LAR able and willing to provide informed consent (verbal) and youth able to provide assent (verbal)
Participant ability: Able and willing to participate in study activities (e.g., co-design discussions, questionnaires, or screening assessments.
Language: English sufficient to comprehend study procedures and materials. Criteria for

Exclusion Criteria

of Participants A potential participant will NOT be eligible for participation in this study if any of the following criteria are met:
Unable to provide informed consent due to cognitive impairment or language barriers
Experiencing acute psychiatric instability at enrollment (e.g., acute psychosis or acute suicidality without stabilization)
Has a medical or psychiatric condition that, in the judgment of the Principal Investigator or study clinician, would place undue risk on the individual or interfere with standard clinical care

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT07622927) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bipolar Disorder (BD) Treatment Options in Dallas, TX

If you're searching for bipolar disorder (bd) treatment options in Dallas, TX, this clinical trial (NCT07622927) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bipolar disorder (bd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bipolar disorder (bd) clinical trials near you to find additional studies recruiting in your area.

More Bipolar Disorder Trials in Dallas, TX

See all bipolar disorder clinical trials recruiting in Dallas — not just this study.

Browse Bipolar Disorder Trials in Dallas

Browse More Trials by Condition

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX